AYYILDIZ, A.; KOC, H.; TURKEKUL, K.; ERDOGAN, S. Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells. Experimental Oncology, [S. l.], v. 43, n. 2, p. 125–134, 2023. DOI: 10.32471/exp-oncology.2312-8852.vol-43-no-2.16096. Disponível em: http://exp-oncology.com.ua/index.php/Exp/article/view/2021-2-5. Acesso em: 16 may. 2026.